Angelika Joos is a licensed pharmacist. Since 2001, she is responsible for Regulatory Policy issues at Merck Sharp & Dohme's Regulatory Affairs department in Brussels. Over the past years, Angelika has gained strategic as well as operational experience with all regulatory procedures and various products in different therapeutic areas.
In her current position as Head Regulatory Policy EU & Most of World she is responsible for monitoring and implementing Regulatory Policies & Procedures and advising the company on Regulatory strategies. She represents MSD in the EFPIA European Regulatory Liaison Committee since 2004 and in the IFPMA RPTS Regulatory Policy Committee since 2011. Her main interests are related to Paediatrics, Clinical Trials, Pharmacovigilance and HTA.